On the other hand, in patients on ARB therapy, ACE inhibitors could limit compensatory angiotensin production. Notably, the beneficial effects on proteinuria of dual RAAS inhibition are ...

Routine use of angiotensin-converting-enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is recommended in proteinuric nontransplant kidney disease patients, to reduce proteinuria and ...

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...